Maria G. Giovannini

Florence, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Protective effects of adenosine A2B receptor antagonism in a cuprizone-induced demyelination model.

Protective effects of adenosine A2B receptor antagonism in a cuprizone-induced demyelination model.

Journal: Neuropharmacology

Published: January 08, 2026

Chronic administration of prebiotics and probiotics prevent pathophysiological hallmarks of Alzheimer's disease in the cortex of APP/PS1 mice.

Chronic administration of prebiotics and probiotics prevent pathophysiological hallmarks of Alzheimer's disease in the cortex of APP/PS1 mice.

Journal: Frontiers in pharmacology

Published: March 19, 2025

Special Issue: Recent Advances in Microglia Research.

Special Issue: Recent Advances in Microglia Research.

Journal: International journal of molecular sciences

Published: December 16, 2024

Prolonged incubation with Δ9-tetrahydrocannabinol but not with cannabidiol induces synaptic alterations and mitochondrial impairment in immature and mature rat organotypic hippocampal slices.

Prolonged incubation with Δ9-tetrahydrocannabinol but not with cannabidiol induces synaptic alterations and mitochondrial impairment in immature and mature rat organotypic hippocampal slices.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: October 24, 2024

Astrocytes phenomics as new druggable targets in healthy aging and Alzheimer's disease progression.

Astrocytes phenomics as new druggable targets in healthy aging and Alzheimer's disease progression.

Journal: Frontiers in cellular neuroscience

Published: October 17, 2024

Chronic administration of prebiotics and probiotics ameliorates pathophysiological hallmarks of Alzheimer's disease in a APP/PS1 transgenic mouse model.

Chronic administration of prebiotics and probiotics ameliorates pathophysiological hallmarks of Alzheimer's disease in a APP/PS1 transgenic mouse model.

Journal: Frontiers in pharmacology

Published: June 18, 2024

Editorial: The role of the microbiota-gut-brain axis in the pathogenesis of neurodegenerative diseases.

Editorial: The role of the microbiota-gut-brain axis in the pathogenesis of neurodegenerative diseases.

Journal: Frontiers in neuroscience

Published: February 29, 2024

Virtual Screening-Accelerated Discovery of a Phosphodiesterase 9 Inhibitor with Neuroprotective Effects in the Kainate Toxicity In Vitro Model.

Virtual Screening-Accelerated Discovery of a Phosphodiesterase 9 Inhibitor with Neuroprotective Effects in the Kainate Toxicity In Vitro Model.

Journal: ACS chemical neuroscience

Published: September 19, 2023

New orphan disease therapies from the proteome of industrial plasma processing waste- a treatment for aceruloplasminemia.

New orphan disease therapies from the proteome of industrial plasma processing waste- a treatment for aceruloplasminemia.

Journal: Communications biology

Published: August 17, 2023

Phenomic Microglia Diversity as a Druggable Target in the Hippocampus in Neurodegenerative Diseases.

Phenomic Microglia Diversity as a Druggable Target in the Hippocampus in Neurodegenerative Diseases.

Journal: International journal of molecular sciences

Published: July 27, 2023

Morphofunctional Investigation in a Transgenic Mouse Model of Alzheimer's Disease: Non-Reactive Astrocytes Are Involved in Aβ Load and Reactive Astrocytes in Plaque Build-Up.

Morphofunctional Investigation in a Transgenic Mouse Model of Alzheimer's Disease: Non-Reactive Astrocytes Are Involved in Aβ Load and Reactive Astrocytes in Plaque Build-Up.

Journal: Cells

Published: July 27, 2023

The Microbiota-Gut-Brain Axis in Behaviour and Brain Disorders.

The Microbiota-Gut-Brain Axis in Behaviour and Brain Disorders.

Journal: International journal of molecular sciences

Published: April 21, 2023

Showing 1-12 of 39

Last Updated: 09/26/2026